Clarivate Q2 Revenue Dips 5.5% on Divestitures, Adjusted EPS Beats Estimates

Clarivate reported a 5.5% year-over-year decline in second-quarter revenue, a result primarily driven by the company's recent divestiture activity. The UK-based data analytics firm posted adjusted earnings that surpassed analyst expectations, while top-line results and adjusted EBITDA came in slightly below consensus forecasts.

Quarterly Performance

Clarivate's revenue for the quarter ending in Q2 2026 was $587.30 million, narrowly missing the average analyst estimate of $589.73 million. The company reported a net loss of $268.60 million for the period.

On an adjusted basis, the results presented a mixed picture for investors:

• Adjusted Earnings Per Share (EPS): Reached $0.19, beating the consensus estimate of $0.18.
• Adjusted Net Income: Came in at $123.10 million, ahead of the $119.69 million forecast.
• Adjusted EBITDA: Totaled $247.20 million, falling short of the consensus forecast of $253.63 million.

Revenue Headwinds and Business Mix

Ad

The company attributed the revenue decline primarily to inorganic divestitures and disposals, including its previously announced sale of the Life Sciences & Healthcare business. Lower transactional revenues, stemming from product group wind-downs and a strategic migration of customers to subscription models, also weighed on the results.

A bright spot in the report was a 0.7% increase in organic subscription revenue. Clarivate said this growth was fueled by new sales and price increases, though it was offset by the declines in other revenue streams.

Full-Year Outlook Maintained

Despite the quarterly revenue dip, Clarivate reaffirmed its full-year guidance for 2026. The company continues to project annual revenue in the range of $2.3 billion to $2.42 billion.

Clarivate also maintained its forecast for adjusted diluted earnings per share between $0.70 and $0.80. The company expects to generate free cash flow ranging from $365 million to $435 million for the full year.